Crinetics Pharmaceuticals
CRNX
#2694
Rank
NZ$8.64 B
Marketcap
$93.27
Share price
-8.28%
Change (1 day)
93.92%
Change (1 year)

P/S ratio for Crinetics Pharmaceuticals (CRNX)

P/S ratio as of November 2024 (TTM): > 1000

According to Crinetics Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.13. At the end of 2024 the company had a P/S ratio of > 1000.

P/S ratio history for Crinetics Pharmaceuticals from 2018 to 2024

PS ratio at the end of each year

Year P/S ratio Change
2024> 1000330.6%
2023592184.9%
2022208-83.43%
2021> 1000
2020N/A
2019N/A
2018N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA